• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

New Wave Subsidiary, Way of Will Inc., to Roll Out All-Natural SPF Lotion in 2022

Microdose by Microdose
March 9, 2021
in Press Releases
Reading Time: 4 mins read
A A

TORONTO, March 9, 2021 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an
investment issuer that provides capital and support services, announces the development of an all-natural SPF lotion to be launched in 2022 that will become a part of Way of Will’s athletic
collection.

Way of Will, a health and wellness brand known for its large selection of high-quality, aromatherapy-based wellness products, is developing an all-natural SPF lotion into its active lifestyle line
which will be introduced next year. This development is a response to customer demands and the company has confirmed buyer interest from key accounts in both Canada
and the U.S. The goal of this development allows us to open doors and enter the global sun-care industry with a market size estimated at 13.03 billion USD in 2019 and
has been steadily climbing and expected to surpass 16.5 billion by 2027.

Joining other popular products that are geared towards athletes and fitness enthusiasts of all levels, the Way of Will SPF lotion will boast the same all-natural, skin-loving properties that many
of Way of Will’s products are known and loved for. The product is being designed and developed by Mr. Iman Navab, one of New Wave’s advisory board members, who is a
homeopathic practitioner, researcher, botanist and historian of homeopathy. Mr. Navab is also the founder of Dynamise, a company that focuses on the development and creation of natural skincare and
health products that are backed by science and research.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

In preparation for the launch, the SPF lotion will soon be undergoing the testing stage to obtain FDA approval. The assessment will involve:

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

  • An in vitro critical wavelength evaluation to test the product’s effectiveness in UVA and UVB radiation protection (the assessment takes approximately one week to complete and is
    required for all products possessing UVA and UVB coverage that has an SPF 15+ claim);
  • A water resistance test spanning approximately six weeks that comprises of an initial screen study
    evaluating the formula’s ability to meet the expected SPF/WR standards, after which a full-panel validation is to be conducted before receiving a formal test result; and
  • A sweat resistance
    test that requires the same evaluation process as the water resistance test.

“The sun-care industry has seen significant growth in recent years due to increasing awareness and discussion
surrounding skin care, skin-damage prevention, and skin protection. North America and Europe make up approximately one-third of the
product consumption in the sun-care market, as these demographics increasingly prioritize overall skin health and skin care,” said Willie, founder and CEO of Way of Will. “This all-natural SPF lotion
is going to be a great addition to our active lifestyle collection. We understand that a lot of sports and physical activities take place outside – especially now with so many gyms and sports
arenas being closed. We want to make sure that our customers have a healthy, natural SPF product that actually works and protects their skin without harsh chemicals found in traditional sun-care
products.”

ABOUT NEW WAVE HOLDINGS CORP.

Order Lasix Now and Save

New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTCPK: TRMNF) is an investment issuer focused on the burgeoning nutraceutical and psychedelic sector and support for adaptive and progressive health
and wellness products and therapies. New Wave subsidiaries contain various health and beauty products within its portfolio of non-psychoactive plants and fungi as it continues to expand its product
distribution through vertical integration to provide end to end solutions while capturing a high margin business model.

Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com.

Information relating to WAY OF WILL INC., contained in this news release was provided by WAY OF WILL INC. and/or its agent and has not been independently verified by the Company. The Company does
not take responsibility for the accuracy of such information.

The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that
term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. 

FORWARD-LOOKING INFORMATION DISCLAIMER

Certain statements contained in this news release may constitute forward–looking information, including but not limited to, applicable regulatory approval in connection with the Acquisition, the
closing of the Acquisition, expansion of operations, size and quality of future tournaments and projections regarding attendance at future events. Forward–looking information is often, but not
always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward–looking information involves known and
unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward–looking information. The Company’s actual results
could differ materially from those anticipated in this forward–looking information as a result of competitive factors and competition for investment opportunities, challenges relating to operations
in international markets, transaction execution risk, changes to the Company’s strategic growth plans, and other factors, many of which are beyond the control of the Company. The Company believes
that the expectations reflected in the forward–looking information are reasonable based on current expectations and potential investment pipeline, but no assurance can be given that these
expectations will prove to be correct and such forward–looking information should not be unduly relied upon. Any forward–looking information contained in this news release represents the
Company’s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward–looking information whether
as a result of new information, future events or otherwise, except as required by applicable securities legislation.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Learn more about the psychedelics industry at Microdose.

Tags: New Wave Holdings
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post

Microdose Launches Special Report Spotlighting Intellectual Property & Patents in Psychedelic Drug Development

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.